Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Netuka

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Texas Heart Institute Journal|October 31, 2012
Implantation of left ventricular assist device complicated by undiagnosed thrombophiliaOndrej Szarszoi, Jiri Maly, Daniel Turek, et al.
Clinical and Experimental Pharmacology & Physiology|August 10, 2006
Effect of perinatal hypoxia on cardiac tolerance to acute ischaemia in adult male and female ratsIvan Netuka, Ondrej Szarszoi, Jiri Maly, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 7, 2009
Single-stage extensive chronic type A dissecting aortic aneurysm repair and continuous-flow ventricular assist device implantationIvan Netuka, Jiri Maly, Ondrej Szarszoi, et al.
Vnitrni Lekarstvi|July 3, 2014
[30 years heart transplantation program in Institute for Clinical and Experimental Medicine in Prague]Lenka Hošková, Ivan Málek, Vojtěch Melenovský, et al.
ESC Heart Failure|August 4, 2021
Increased pulsatility index is associated with adverse outcomes in left ventricular assist device recipientsZuzana Tucanova, Peter Ivak, Peter Wohlfahrt, et al.
Neuro Endocrinology Letters|November 28, 2012
The impact of left ventricle assist device on circulating endothelial microparticles - pilot studyJan Pitha, Zora Dorazilova, Vojtech Melenovsky, et al.
Casopis Lekaru Ceskych|March 17, 2011
[Benefit of paracorporeal pulsatile assist device in multiorgan failing patients in terminal stage of heart failure]Ivan Netuka, Jirí Malý, Hynek Ríha, et al.
The Canadian Journal of Cardiology|June 6, 2021
The Effect of Artificial Pulsatility on the Peripheral Vasculature in Patients With Continuous-Flow Ventricular Assist DevicesPeter Ivak, Ivan Netuka, Zuzana Tucanova, et al.
Current Drug Metabolism|May 20, 2017
Rivaroxaban - Metabolism, Pharmacologic Properties and Drug InteractionsTomas Kvasnicka, Ivana Malikova, Zuzana Zenahlikova, et al.
Croatian Medical Journal|September 3, 2016
B-type natriuretic peptide: powerful predictor of end-stage chronic heart failure in individuals with systolic dysfunction of the systemic right ventricleMarketa Hegarova, Jaroslav Brotanek, Milos Kubanek, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Texas Heart Institute Journal|October 31, 2012
Implantation of left ventricular assist device complicated by undiagnosed thrombophiliaOndrej Szarszoi, Jiri Maly, Daniel Turek, et al.
Clinical and Experimental Pharmacology & Physiology|August 10, 2006
Effect of perinatal hypoxia on cardiac tolerance to acute ischaemia in adult male and female ratsIvan Netuka, Ondrej Szarszoi, Jiri Maly, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 7, 2009
Single-stage extensive chronic type A dissecting aortic aneurysm repair and continuous-flow ventricular assist device implantationIvan Netuka, Jiri Maly, Ondrej Szarszoi, et al.
Vnitrni Lekarstvi|July 3, 2014
[30 years heart transplantation program in Institute for Clinical and Experimental Medicine in Prague]Lenka Hošková, Ivan Málek, Vojtěch Melenovský, et al.
ESC Heart Failure|August 4, 2021
Increased pulsatility index is associated with adverse outcomes in left ventricular assist device recipientsZuzana Tucanova, Peter Ivak, Peter Wohlfahrt, et al.
Neuro Endocrinology Letters|November 28, 2012
The impact of left ventricle assist device on circulating endothelial microparticles - pilot studyJan Pitha, Zora Dorazilova, Vojtech Melenovsky, et al.
Casopis Lekaru Ceskych|March 17, 2011
[Benefit of paracorporeal pulsatile assist device in multiorgan failing patients in terminal stage of heart failure]Ivan Netuka, Jirí Malý, Hynek Ríha, et al.
The Canadian Journal of Cardiology|June 6, 2021
The Effect of Artificial Pulsatility on the Peripheral Vasculature in Patients With Continuous-Flow Ventricular Assist DevicesPeter Ivak, Ivan Netuka, Zuzana Tucanova, et al.
Current Drug Metabolism|May 20, 2017
Rivaroxaban - Metabolism, Pharmacologic Properties and Drug InteractionsTomas Kvasnicka, Ivana Malikova, Zuzana Zenahlikova, et al.
Croatian Medical Journal|September 3, 2016
B-type natriuretic peptide: powerful predictor of end-stage chronic heart failure in individuals with systolic dysfunction of the systemic right ventricleMarketa Hegarova, Jaroslav Brotanek, Milos Kubanek, et al.
Pageof 13